Source:http://linkedlifedata.com/resource/pubmed/id/21860351
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-8-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1944-7884
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e58-61
|
pubmed:meshHeading |
pubmed-meshheading:21860351-Adult,
pubmed-meshheading:21860351-Antigens, CD30,
pubmed-meshheading:21860351-Female,
pubmed-meshheading:21860351-HIV Infections,
pubmed-meshheading:21860351-Humans,
pubmed-meshheading:21860351-Lymphoma, Non-Hodgkin,
pubmed-meshheading:21860351-Male,
pubmed-meshheading:21860351-Middle Aged,
pubmed-meshheading:21860351-Receptors, IgE
|
pubmed:year |
2011
|
pubmed:articleTitle |
Can serum soluble CD23 or CD30 predict the occurrence of lymphoma in HIV-infected patients?
|
pubmed:publicationType |
Letter
|